Caen J - Search Results

1

Changes in plasma fibrin degradation products as a marker of thrombus evolution in patients with deep vein thrombosis.

Mirshahi M, Soria C, Soria J, Mirshahi M, Faivre R, Kieffer Y, Bassand JP, Toulemonde F, Caen J. Mirshahi M, et al. Among authors: caen j. Thromb Res. 1988 Aug 1;51(3):295-302. doi: 10.1016/0049-3848(88)90106-5. Thromb Res. 1988. PMID: 3175985

2

Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolism.

Faivre R, Mirshahi M, Ducellier D, Soria C, Soria J, Mirshahi M, Kieffer Y, Bassand JP, Caen J, Maurat JP. Faivre R, et al. Among authors: caen j. Thromb Res. 1988 May 15;50(4):583-9. doi: 10.1016/0049-3848(88)90206-x. Thromb Res. 1988. PMID: 3413720 No abstract available.

3

Degradation of fibrinogen by tissue plasminogen activator. Consequences for fibrin polymerization.

Mirshahi M, Soria J, Soria C, Samama M, Caen JP. Mirshahi M, et al. Among authors: caen jp. Thromb Res Suppl. 1990;10:21-6. doi: 10.1016/0049-3848(90)90375-m. Thromb Res Suppl. 1990. PMID: 2107597

4

Fibrinolytic and thrombolytic parameters in patients with deep vein thrombosis treated by low molecular weight and standard heparin.

Faivre R, Neuhart E, Mirshahi M, Mirshahi M, Soria C, Soria J, Bassand JP, Caen JP, Maurat JP. Faivre R, et al. Among authors: caen jp. Semin Thromb Hemost. 1989 Oct;15(4):435-9. doi: 10.1055/s-2007-1002743. Semin Thromb Hemost. 1989. PMID: 2554504 No abstract available.

5

Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study.

Carvalho de Sousa J, Bruckert E, Giral P, Soria C, Truffert J, Mirshahi MC, de Gennes JL, Caen JP. Carvalho de Sousa J, et al. Among authors: caen jp. Haemostasis. 1989;19(2):83-90. doi: 10.1159/000215895. Haemostasis. 1989. PMID: 2731779

6

Defective thrombolysis due to collagen incorporation in fibrin clots.

Mirshahi M, Soria J, Lu H, Soria C, Samama M, Caen JP. Mirshahi M, et al. Among authors: caen jp. Thromb Res Suppl. 1988;8:73-80. doi: 10.1016/0049-3848(88)90156-9. Thromb Res Suppl. 1988. PMID: 3144770

7

Dynamic coronary fibrinolysis evaluation in patients with myocardial infarction and unstable angina by specific plasma fibrin degradation product determination.

Soria C, Soria J, Mirshahi M, Mirshahi M, Dunnica S, Boucheix C, Beaufils R, Slama R, Caen JP. Soria C, et al. Among authors: caen jp. Thromb Res. 1987 Feb 15;45(4):383-92. doi: 10.1016/0049-3848(87)90227-1. Thromb Res. 1987. PMID: 3576522

8

Pharmacological approaches of fibrin gel architecture modulation and thrombus degradation: its implication in atherogenesis and thromboembolism disease.

Collet JP, Mishal Z, Vasse M, Mirshahi M, Caen JP, Soria C, Soria J. Collet JP, et al. Among authors: caen jp. Thromb Res. 1994 Aug 1;75(3):353-9. doi: 10.1016/0049-3848(94)90250-x. Thromb Res. 1994. PMID: 7992248 No abstract available.

9

Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation.

Cariou R, Tobelem G, Bellucci S, Soria J, Soria C, Maclouf J, Caen J. Cariou R, et al. Among authors: caen j. Thromb Haemost. 1988 Aug 30;60(1):54-8. Thromb Haemost. 1988. PMID: 2847352

10

Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure.

Collet JP, Soria J, Mirshahi M, Hirsch M, Dagonnet FB, Caen J, Soria C. Collet JP, et al. Among authors: caen j. Blood. 1993 Oct 15;82(8):2462-9. Blood. 1993. PMID: 7691261 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

622 results

Search Page

Filters